Carriers of mutations in the glucocerebrosidase (GBA) gene are at risk of developing neurological structural abnormalities in the subcortical and brainstem regions, a hallmark of parkinsonian symptoms.
News News Daily digests from key neurology conferences, written by on-site medical journalists.